Abstract:Matrine, one of the major active alkaloids isolated from the Sophora alopecuroides L which is a useful Chinese herbal drug, possesses antipyretic, anti-inflammatory, analgesic, and notable antiviral activities, and has been used for the treatment of lipopolysaccharide-induced liver injury. Recently, it was reported that matrine could inhibit the growth of tumor cells. Nitric oxide(NO), a free radical molecule, is involved in numerous physiological and pathological processes. High levels of NO usually are toxic to tumor cells. It was therefore of interest to determine whether the hybrid of matrine and NO donor furoxan would provide a hitherto unknown class of matrine derivatives that possess potent anticancer activity. Herein furoxan-based matrine compounds 11a-11m were designed and synthesized, and their structures were confirmed by MS, IR, H-1 NMR spectra and elemental analysis. All target compounds exhibited expectedly much more stronger anti human hepatocellular carcinoma cells(HepG2 cells) activity than that of parent compound matrine in vivo. Furthermore, compounds 11a-11c, 11h and 11i had stronger cytotoxic activities than that of control 5-flu-orouracil. The concept of designing NO donor-based matrine derivatives that possess potent anticancer activity warrants further investigation.

Synthesis and Bioactivity of Furoxan-Based Nitric Oxide-Releasing Colchicine Derivatives As Anticancer Agents

Synthesis and Biological Evaluation of Nitrate Derivatives of Thiocolchicine as Potential Anticancer Drugs

Synthesis and Cytotoxic Evaluation of Novel C-10 Nitrate Derivatives of Colchicine

Synthesis and in Vitro Cytotoxic Activity of Some New Colchicine Analogues

Synthesis and Biological Evaluation of Nitric Oxide-Releasing Matrine Derivatives As Anticancer Agents

Synthesis and Biological Evaluation of Novel Furozan-Based Nitric Oxide-Releasing Derivatives of Oridonin As Potential Anti-Tumor Agents.

Synthesis and Biological Evaluation of Nitric Oxide-Releasing Sixalkoxyl Biphenyl Derivatives As Anticancer Agents

Synthesis and Biological Evaluation of Novel Uracil and 5-Fluorouracil-1-yl Acetic Acid-Colchicine Conjugate

Synthesis of Novel Furozan-Based Nitric Oxide-Releasing Derivatives of 1-Oxo-oridonin with Anti-Proliferative Activity

Synthesis of Flavone Derivatives via N-Amination and Evaluation of Their Anticancer Activities

Synthesis and Antitumor Activity of Nitrogen-Based Thiocolchicine Derivatives.

Synthesis and biological evaluation of furoxan-based nitric oxide-releasing derivatives of glycyrrhetinic acid as anti-hepatocellular carcinoma agents.

Design, Synthesis, and Biological Evaluation of Novel N-γ-carboline Arylsulfonamides As Anticancer Agents.

Synthesis and Cytotoxic Evaluation of New Colchicine Derivatives Bearing 1,3,4-Thiadiazole Moieties

Synthesis and Evaluation of Furoxan-Based Nitric Oxide-Releasing Derivatives of Tetrahydroisoquinoline As Anticancer and Multidrug Resistance Reversal Agents

Synthesis and Evaluation of Nitric Oxide-Releasing Derivatives of Farnesylthiosalicylic Acid As Anti-Tumor Agents.

Synthesis and Anti-cancer Activity of Nitric Oxide Donor-based Matrine Derivatives

Design, synthesis and antitumor activity of novel cis-furoquinoline derivatives

Novel Nitric Oxide-Releasing Derivatives of Farnesylthiosalicylic Acid: Synthesis and Evaluation of Antihepatocellular Carcinoma Activity.

Synthesis and Biological Evaluation of a Novel Class of Coumarin Derivatives.

Novel Nitric Oxide Donors of Phenylsulfonylfuroxan and 3-Benzyl Coumarin Derivatives As Potent Antitumor Agents